The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
210 - Would PAAB approval be required for cards containing the Ontario Drug Benefit (ODB) Reimbursement Codes for a drug class? *content is copied verbatim from the ODB website *OBD website/URL is referenced *no mention of drug name or drug logo *no mention of pharmaceutical company *to be distributed by drug rep
-
Caution should be used when editing official government documents, which you are basically doing here. Context is important. You may want to seek permission from ODB to edit the information in the manner you are stating. The PAAB has received complaints from provinces about some marketing activities that included editing information or forms. If no drugs are mentioned, and the province has no objection, the item would not require PAAB review. It is better to hand out the entire published document, unedited.
